Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, PA.
Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL.
Clin Lung Cancer. 2020 Jul;21(4):e274-e285. doi: 10.1016/j.cllc.2020.01.002. Epub 2020 Jan 23.
Lymph node (LN) involvement is a poor prognostic factor for malignant pleural mesothelioma (MPM). However, to our knowledge, postresection outcomes of node-negative (cN0/pN0), occult pathologic nodal disease (cN0/pN+), and clinical node-positive disease (cN+) have not been compared to date.
The National Cancer Data Base was queried for newly diagnosed, resected MPM with known clinical/pathologic LN information. Three cohorts were compared: cN0/pN0, cN+, and cN0/pN+. Multivariable logistic regression examined predictors of pathologic nodal upstaging. Kaplan-Meier analysis with propensity matching assessed overall survival (OS); multivariate Cox proportional hazards modeling examined predictors thereof.
Of 1369 patients, 687 (50%) had cN0/pN0, 457 (33%) cN+, and 225 (16%) cN0/pN+ disease. Median follow-up was 29 months. In patients with cN0 disease, factors associated with pathologic nodal upstaging were younger age, greater number of examined LNs, and nonsarcomatoid histology (P < .05 for all). Relative to pN0 cases, occult LN involvement (65% being pN2) was associated with 51% higher hazard of mortality on multivariate analysis (P = .005). Following propensity matching, the OS of cN0/pN+ was similar to cN+ cases (P = .281). On multivariate analysis, the number of involved LNs (continuous variable, P = .013), but not nodal tumor, node, metastasis (TNM) classification or LN ratio (P > .05 for both), was associated with OS.
Detecting occult nodal disease during resection for cN0 MPM is associated with poorer prognosis, with similar survival as cN+ cases, underscoring the importance of routine preoperative pathologic nodal assessment for potentially resectable MPM. The number of involved LNs (rather than current location-based classification) may provide more robust prognostic stratification for future TNM staging.
淋巴结(LN)受累是恶性胸膜间皮瘤(MPM)不良预后的一个因素。然而,据我们所知,目前尚未比较淋巴结阴性(cN0/pN0)、隐匿性病理淋巴结疾病(cN0/pN+)和临床淋巴结阳性(cN+)患者的术后结局。
国家癌症数据库(National Cancer Data Base)中检索新诊断为经手术切除且具有已知临床/病理淋巴结信息的 MPM 患者。比较了 3 个队列:cN0/pN0、cN+和 cN0/pN+。多变量逻辑回归分析了病理淋巴结升级的预测因素。采用倾向评分匹配的 Kaplan-Meier 分析评估总生存期(OS);多变量 Cox 比例风险模型分析了其预测因素。
在 1369 例患者中,687 例(50%)为 cN0/pN0,457 例(33%)为 cN+,225 例(16%)为 cN0/pN+。中位随访时间为 29 个月。在 cN0 疾病患者中,与病理淋巴结升级相关的因素包括年龄较小、检查的淋巴结数量较多和非肉瘤样组织学(所有 P <.05)。与 pN0 病例相比,隐匿性 LN 受累(65%为 pN2)在多变量分析中与死亡率增加 51%相关(P =.005)。经过倾向评分匹配后,cN0/pN+的 OS 与 cN+病例相似(P =.281)。多变量分析显示,受累淋巴结数量(连续变量,P =.013),而不是淋巴结肿瘤、淋巴结、转移(TNM)分类或淋巴结比值(两者均 P >.05)与 OS 相关。
在 cN0 MPM 的切除术中检测隐匿性淋巴结疾病与预后较差相关,与 cN+病例的生存相似,这强调了对潜在可切除的 MPM 进行常规术前病理淋巴结评估的重要性。受累淋巴结数量(而不是当前基于位置的分类)可能为未来的 TNM 分期提供更稳健的预后分层。